RISA Labs has raised $3.5 million seed round to help healthcare organizations eliminate one of the most persistent barriers to timely cancer care.
The seed was led by Binny Bansal (Flipkart co-founder) with participation from Oncology Ventures, General Catalyst, z21 Ventures, ODD BIRD VC, and Ashish Gupta. The capital will accelerate deployments in the next 100 cancer centers across the country within the next two years.
Also read – Chapter Raises $75 Mn Series D Funding Led by Stripes
“Prior authorizations remain one of the least automated parts of our healthcare system,” said Ben Freeberg, Managing Partner at Oncology Ventures. “In oncology, the stakes are higher. 70% of cancer patients experience delays in care because of prior authorization requirements. In 33% of those cases, the delay is one month—a time window that can increase the risk of death by 13% in certain cancer types. The current system isn’t just inefficient – it’s dangerous.”
RISA’s platform – Business Operating System as a Service (BOSS) – is not another automation bot or AI assistant. It’s a full-stack orchestration engine built for the vertical complexity of healthcare. Instead of relying on humans to push paperwork or brittle bots that break when systems change, BOSS decomposes complex workflows into micro-tasks, then delegates them to a network of intelligent agents: LLMs, digital twins, and reinforcement learners, extending across an institution’s entire software stack.
Also read – Auradine Secures $153 Million in Series C Funding
“We’ve had Windows, we’ve had Linux, we’ve had Mac, each OS helped humans extract more from machines. But now, we’re drowning in software. There’s too much of it, and a shortage of skilled labor to operate it. Software that was supposed to get work done has become work itself,” Kshitij Jaggi, co-founder and CEO of RISA Labs adds. “BOSS is an AI OS designed for the post-ChatGPT era: where work is no longer about learning tools, but simply expressing intent.”
“Cancer care is time sensitive. Every delay in treatment can affect outcomes. Prior authorizations continue to slow us down. What RISA is building is not just smart technology. It removes barriers so our teams can move faster and stay focused on what matters most: caring for patients,” said Dr. Jeffrey Vacirca, CEO of New York Cancer and Blood Specialists.
Also read – Healthtech Startup Well Raises $30 Million Funding
About RISA Labs
Founded by Kshitij Jaggi and Kumar Shivang, repeat founders and IIT Kanpur alumni, RISA is the product of a decade-long friendship and a shared frustration with slow, fragmented healthcare workflows. It inspired the duo to take a systems-first approach, leading them to develop a foundational AI operating system that can simulate, understand, and orchestrate entire institutional workflows from end to end.
Also read – QWERKY AI Raises $2 Mn Seed Funding
